This Is The Best Time To Invest In Cannabis Stocks

Posted on by The INO.com Team

Analysis originally distributed on March 22, 2017 By: Michael Vodicka of Cannabis Stock Trades

If you are the kind of person who loves getting a great deal, the cannabis sector is calling your name.

Cannabis stocks are officially on sale.

This blast of weakness has been driven by two things.

There are still lingering concerns over US drug policy after some questionable comments on cannabis enforcement from White House Press Secretary, Sean Spicer.

I think these concerns are overblown - read my full analysis - but none the less, it has definitely been a lingering concern and weighed on cannabis stocks.

Canada also recently spooked cannabis stocks a bit.

Canada's cannabis czar said the country won't rush legalizing recreational cannabis in order to make sure it is done properly.

BIG NEWS!!! We're now accepting new Cannabis Stock Trades Premium members!

This may look like bad news on the surface. For shareholders, it's never fun watching a stock you own do anything but go up. For potential shareholders, it can be intimidating to buy a stock that has been falling.

However, I am hear to tell you this weakness is creating a great opportunity. Continue reading "This Is The Best Time To Invest In Cannabis Stocks" →

Markets Mixed As Brexit Starts

Posted on by The INO.com Team

Hello MarketClub members everywhere. The markets are mixed Wednesday as traders assess the start of Brexit, which is Britain's divorce from the European Union. Of course, this was expected, and the market's reaction shows that.

MarketClub's Mid-day Market Report

Crude oil is on the move today, gaining almost 2% on the second day of gains. This came after the government reported a larger-than-projected decline in U.S. gasoline inventories.

Key levels to watch this week: Continue reading "Markets Mixed As Brexit Starts" →

What Happens When The Fed Starts Selling?

Posted on by George Yacik

George Yacik - INO.com Contributor - Fed & Interest Rates


The financial markets have been fixated for years at the prospect of interest rate increases by the Federal Reserve but have largely ignored the $4.5 trillion elephant in the room, namely the Fed’s gargantuan balance sheet. But last week several members of the Fed began publicly discussing their support to finally start winding down that massive portfolio.

Way back before the global financial crisis, the Fed’s portfolio held pretty steady in the high $800 billion to low $900 billion range. Then, as the crisis hit full force in the last three months of 2008 after the Lehman Brothers collapse, the portfolio more than doubled, ending that year at slightly north of $2 trillion. While the worst of the crisis may have been reached at that point, that was only the beginning of the balance sheet’s growth.

Between the end of 2008 until the end of 2012, the Fed’s portfolio grew gradually by another $800 billion or so, before spiking again, adding another $2 trillion over the next two years as the Fed embarked on quantitative easing. Eventually the portfolio reached $4.5 trillion, including both Treasury and mortgage-backed securities, at the end of 2014, where it has held largely steady ever since. Continue reading "What Happens When The Fed Starts Selling?" →

CVS Health Check - Stock Appears To Be Consolidating

Posted on by Noah Kiedrowski

Noah Kiedrowski - INO.com Contributor - Biotech


Introduction

It’s time for a health check for CVS Health Corporation (NYSE:CVS) after reporting its most recent quarterly earnings and seeing its stock move in a wide range over the past few months. CVS reported what was ostensibly another great quarter and full-year numbers, reporting a full-year increase of 25.1%, 13.2% and 11.7% in free cash flow, EPS and revenue, respectively. After reporting its Q4 earnings, CVS held steady in contrast to the massive 17% sell-off after reporting its Q3 numbers, moving down from $84 to $70. I’ve written several articles contending that CVS presents a compelling investment opportunity in the ever expanding healthcare space. My investment thesis was based on sector consolidation, aging population and growth in long-term care facilities in combination with the fact that CVS has been highly acquisitive, continues to deliver robust earnings growth, revenue growth, growing dividends and has an aggressive share buyback program in place. With its recent acquisitions of Target’s pharmacies and Omnicare, these proactive measures will significantly expand its presence and ability to dispense prescriptions to the general public and in long-term care facilities. As health care costs and prescription drug costs continue to rise and the population continues to age with the elderly comprising a larger segment of the overall population, CVS looked poised to benefit. However, during the Q3 earnings call CVS noted that recent marketplace trends had forced CVS to cut guidance for Q4 2016 and the full-year 2017 numbers. This guide-down negatively impacted shares however the long-term narrative remains intact. CVS has strong fundamentals and growth and I felt that the previous sell-off after the Q3 release was an overreaction. Since then, Q4 numbers have been released and the share price has retraced the low $80 range and appears to be consolidating for another move up. Continue reading "CVS Health Check - Stock Appears To Be Consolidating" →

Stocks Recover From Early Losses

Posted on by The INO.com Team

Hello MarketClub members everywhere. Stocks have bounced back from their session lows as traders turn their attention to some key White House proposals that include tax reform.

The Dow was down as much as 183 pts this morning, continuing an eight-day streak of losses The S&P 500 pulled back 0.1%, also off its session lows. The Nasdaq has recovered from earlier losses to trade 0.2% higher.

MarketClub's Mid-day Market Report

Crude oil has fallen today, continuing the trend from last week as a pledge by OPEC-led producers to consider extending their output cut deal failed to excite traders. They expressed concern that they will need more time to trim global stockpiles.

Key levels to watch this week: Continue reading "Stocks Recover From Early Losses" →